Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
An initial targeted literature review was performed by Medlior Health Outcomes Research Ltd. (Medlior; Calgary, AB, Canada), an independent research organization, to identify information related to the topical therapy landscape of PsO and the efficacy, safety, patient adherence/preference, and cost effectiveness of HP/TAZ. A total of 29 publications were identified. A summary of the literature review was provided as an evidence package to the expert panel.
Copyright and License information: The Author(s) ©2024
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
